FTH

Conviction 0HealthcareScan · Wed, Sep 16, 2026

Faeth Therapeutics, Inc. (FTH) closed at $35.37 (-9.52%) on Sep 16, 2026. Price is above its 50-day. RSI(14) 53, -11.7% from its 52-week high, +143.4% year to date. Sector: Healthcare · Pharmaceutical Preparations.

FTH$35.37-9.52%

ResistanceSupportVol 14

Sep 1Sep 3Sep 8Sep 9Sep 11Sep 15

Faeth Therapeutics, Inc.Pharmaceutical Preparations

Price35.37

Change-9.52%

Gap-0.87%

Rel volume0.67×

Avg volume300.25K

Avg $ vol10.74M

SMA 2035.58

SMA 5031.54

SMA 200—

Price vs 50+12.16%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 31.20

RSI (14)53

MACD hist-0.18

MACD crossbear · 0d

Stoch %K / %D35 / 55

ADX (14)35

+DI / −DI21 / 15

RSI divergence—

MACD divergence—

ATR %+10.06%

ADR %9.39%

52w high40.05

52w low14.53

From 52w high-11.69%

Above 52w low+143.43%

New 52w highNo

SqueezeOff

Bollinger width30.47%

%B0.48

Donchian pos42.81%

Donchian high42.14

Donchian low30.30

AVWAP (52w high)38.21

vs AVWAP high-7.44%

AVWAP (52w low)30.73

vs AVWAP low+15.12%

OBV trendFlat

Chaikin MF (20)0.01

Today vs 20d0.67×

Avg vol (14d)275.97K

Avg vol (20d)300.25K

Avg $ vol (20d)10.74M

Market cap913.98M

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank80.5

1 week-9.77%

1 month+9.37%

3 months—

6 months—

1 year—

YTD+143.43%

P/E-43.35

P/B5.28

P/S—

P/FCF-44.65

EPS-16.72

Div yield—

ROE-12.19%

ROA-11.14%

Debt/Eq0.00

Current19.69

EV/EBITDA-40.05

Gross margin—

Net margin—

Rev growth—

EPS growth30.08%

Price target57.64

Target upside62.96%

Analyst ratingBuy

Institutional54.46%

Ent. value887.64M

Revenue—

Net income-16.01M

Gross profit—

Free cash flow-20.47M

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float200.74K

Float %0.8%

Short interest1.1M

Days to cover3.7d

Short volume71.8%

Squeeze score78 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$2.84 vs −$1.10

Last surprise-158.2% miss

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank80.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance41.32

Support26.71

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FTH

All disclosures →

No recent disclosed trades by Congress in FTH. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FTH · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Vousden Karen H Director · Stock Option (right to buy) · 2026-09-11	Grant	25K	—	2026-09-11	2026-09-15

SEC filings

EDGAR filings in FTH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.